Infectious disease
VP1 36-44 (HLA-A*02:01) SITEVECFL
Product number: EP11457_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
SITEVECFL is a linear peptidic epitope (epitope ID58721) studied as part of Human polyomavirus 2 protein from Human polyomavirus 2. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays. The epitope stabilized the expression of HLA-A*02:01 on T2 cells.
TechData
| Sequence: | SITEVECFL |
| Gene: | VP1 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Major capsid protein VP1 |
| UniProt Id: | P03089 |
| IEDB Id: | 58721 |
| Species: | JC polyomavirus (JCPyV) (JCV) |
| Allele: | HLA-A*02:01 |
| Application: | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |